Skip to content
Altius – Lifestyle
Author:
Prometheus Laboratories
Prometheus Laboratories Presents Research Showing Superior Performance of MASH Precis Fibrosis Score in Identifying Treatment-Eligible Patients
November 6, 2026
Prometheus Laboratories Launches MASH Precis, a Purpose-Built Non-Invasive Test Designed to Support Evolving MASH Pathways
October 13, 2026
Celltrion USA and Prometheus Laboratories Inc. Announce Sponsored Testing Collaboration on Anser IFX for ZYMFENTRA (infliximab-dyyb)
July 6, 2026